v3.24.0.1
Condensed Financial Information of Parent Company - Schedule of Parent-only Statement of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Equity in loss of subsidiary      
Net cash provided by operating activities $ 138,292,000 $ 146,780,000 $ 178,779,000
Cash flows from investing activities      
Distribution from subsidiary 0 0 0
Net cash used in investing activities (55,766,000) (210,498,000) (178,733,000)
Cash flows from financing activities      
Repurchases of Class A common stock [1] 103,974,000 101,721,000 0
Proceeds from exercise of stock options 5,941,000 9,159,000 35,021,000
Employee taxes paid related to net share settlement of equity awards (65,481,000) (20,635,000) (57,688,000)
Proceeds from employee stock purchase plan 1,390,000 0 0
Net cash used in financing activities (167,395,000) (120,226,000) (30,528,000)
Net change in cash and cash equivalents (84,869,000) (183,944,000) (30,482,000)
Cash      
Beginning of period 757,165,000 941,109,000 971,591,000
End of period 672,296,000 757,165,000 941,109,000
GoodRx Holdings, Inc      
Cash flows from operating activities      
Net loss (8,868,000) (32,828,000) (25,254,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Equity in loss of subsidiary 8,868,000 32,828,000 25,254,000
Equity in loss of subsidiary      
Other assets (164,000) 80,000 (23,000)
Other current liabilities 1,000 0 (87,000)
Net cash provided by operating activities (163,000) 80,000 (110,000)
Cash flows from investing activities      
Distribution from subsidiary 162,287,000 113,117,000 22,777,000
Net cash used in investing activities 162,287,000 113,117,000 22,777,000
Cash flows from financing activities      
Repurchases of Class A common stock (103,974,000) (101,721,000) 0
Proceeds from exercise of stock options 5,941,000 9,159,000 35,021,000
Employee taxes paid related to net share settlement of equity awards (65,481,000) (20,635,000) (57,688,000)
Proceeds from employee stock purchase plan 1,390,000 0 0
Net cash used in financing activities (162,124,000) (113,197,000) (22,667,000)
Net change in cash and cash equivalents 0 0 0
Cash      
Beginning of period 5,000 5,000 5,000
End of period $ 5,000 $ 5,000 $ 5,000
[1] Repurchases of Class A common stock for the year ended December 31, 2023 include 12.0 million shares repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class A common stock upon such repurchase) for an aggregate consideration of $65.9 million. See "Note 14. Stockholders' Equity" for additional information.